ストックスクリーナーアプリを入手
9.235
12.08%
0.995
アフターアワーズ：
9.26
0.025
+0.27%
Precision Biosciences Inc (DTIL) 最新ニュース
Enterprise value to revenue forward of Precision BioSciences, Inc. – NASDAQ:DTIL - TradingView
Precision BioSciences Updates Investors with Latest Corporate Deck in July 2026 SEC 8-K Filing - Minichart
Precision BioSciences Advances Gene-Editing Programs in Hepatitis B - TipRanks
Precision BioSciences (NASDAQ: DTIL) shares HBV data, DMD trial timeline - Stock Titan
Precision BioSciences, Inc.(NasdaqCM: DTIL) added to Russell 2000 Index - marketscreener.com
Precision BioSciences, Inc.(NasdaqCM: DTIL) added to Russell 2000 Value Benchmark - marketscreener.com
Precision BioSciences added to Russell 2000 index - Investing.com
Precision BioSciences (DTIL) Joins Russell 2000 Index, Highlighting Growth Potential - GuruFocus
Index Expanding Market Visibility with Institutional Investors - Business Wire
Precision BioSciences, Inc.(NasdaqCM: DTIL) added to Russell 3000 Index - marketscreener.com
Precision BioSciences, Inc.(NasdaqCM:DTIL) added to Russell Small Cap Completeness Index - marketscreener.com
Precision BioSciences, Inc. Actuals & Estimates (DUS:PBS0) - TradingView
Price to sales forward of Precision BioSciences, Inc. – NASDAQ:DTIL - TradingView
Precision BioSciences Inc (DTIL) Valuation: PE, PB & Fair Value Analysis - TradingKey
Price to earnings forward of Precision BioSciences, Inc. – NASDAQ:DTIL - TradingView
Precision BioSciences, Inc. Actuals & Estimates (NASDAQ:DTIL) - TradingView
Enterprise value to EBIT forward of Precision BioSciences, Inc. – LS:A400AS - TradingView
Enterprise value to revenue forward of Precision BioSciences, Inc. – LS:A400AS - TradingView
DTIL Forecast — Price Target — Prediction for 2027 - TradingView
Precision BioSciences earnings calendar and gene-editing focus, shares remain a small-cap biotech pl - AD HOC NEWS
Precision BioSciences Inc (DTIL) Institutional Confidence - TradingKey
Greenstone Biosciences And Intel Collaborate To Accelerate AI Driven Drug Discovery - BioPharma APAC
Precision BioSciences Inc (DTIL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Precision BioSciences (DTIL) AGM 2026 Summary - Quartr
Precision BioSciences Inc (DTIL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Precision BioSciences Inc (DTIL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Precision BioSciences Inc (DTIL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Precision BioSciences Inc (DTIL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Precision BioSciences Inc (DTIL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Precision BioSciences Inc (DTIL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Precision BioSciences Extends Term Loan Maturity to 2029 - TipRanks
Precision BioSciences Extends Term Loan Maturity to 2029 in Amendment With Banc of California - TradingView
Precision BiosciencesEnters First Amendment To Loan And Security Agreement With Banc Of CaliforniaSEC Filing - TradingView
Precision BioSciences (NASDAQ: DTIL) amends loan and extends term to 2029 - Stock Titan
Precision BioSciences, Inc. Amends Loan and Security Agreement with Banc of California - marketscreener.com
Oppenheimer Maintains Precision BioSciences(DTIL.US) With Buy Rating, Raises Target Price to $20 - Moomoo
DTIL Initiated Coverage by Oppenheimer -- Rating Set to Outperfo - GuruFocus
These stocks are gapping in today's session - ChartMill
Bio Preventive Medicine and Precision Diabetes Announce ADA Late-Breaking Presentation Highlighting DNlitetm in Landmark CREDENCE Trial - Lelezard
[Form 4] PRECISION BIOSCIENCES INC Insider Trading Activity - Stock Titan
Director at Precision Bio (NASDAQ: DTIL) receives 20,979 restricted stock units - Stock Titan
Precision Biosciences (DTIL) director receives grant of 20,979 restricted stock units - Stock Titan
Precision BioSciences (DTIL) director receives grant of 20,979 RSUs - Stock Titan
Precision BioSciences stock (US74019P1084): shares edge higher amid biotech volatility - AD HOC NEWS
H.C. Wainwright Reaffirms Their Buy Rating on Precision BioSciences (DTIL) - The Globe and Mail
Executive at Precision BioSciences (DTIL) receives 57,389 RSU compensation award - Stock Titan
Precision BioSciences (DTIL) awards 107,604 RSUs to General Counsel - Stock Titan
Precision BioSciences (NASDAQ: DTIL) CEO receives 573,888 restricted stock units - Stock Titan
Precision BioSciences (DTIL) Jefferies Global Healthcare 2026 Conference Summary - Quartr
Tyra Biosciences Expands Precision Oncology Clinical Pipeline - asatunews.co.id
Analysts Conflicted on These Healthcare Names: MannKind (MNKD), Biohaven Ltd. (BHVN) and Precision BioSciences (DTIL) - The Globe and Mail
DTIL Stock Chart | PRECISION BIOSCIENCES INC (NASDAQ:DTIL) - ChartMill
Guggenheim Maintains Precision BioSciences(DTIL.US) With Buy Rating, Maintains Target Price $19 - Moomoo
Precision BioSciences Announces New and Late-Breaking PBGENE-HBV Clinical Data from the ELIMINATE-B Study at European Association for the Study of the Liver Congress 2026 - New Castle News
Precision BioSciences Shareholders Approve Incentive Plan and Directors - The Globe and Mail
DTIL Reiterates by HC Wainwright & Co. -- Price Target Maintained at $60 - GuruFocus
Precision BioSciences (DTIL) Unveils Groundbreaking Data on PBGE - GuruFocus
Precision BioSciences Put Its ARCUS Gene Editing Data Front And Center - Finimize
Precision BioSciences, Inc. (DTIL) Discusses Updates on PBG and HBV Program and ELIMINATE-B Trial ResultsSlideshow (NASDAQ:DTIL) 2026-05-27 - Seeking Alpha
Precision BioSciences stock jumps on hepatitis B trial data By Investing.com - Investing.com South Africa
Precision BioSciences stock jumps on hepatitis B trial data - Investing.com
1.18%
2.48%
大文字化:
|
ボリューム (24 時間):